SPANSIV
DEAD

Serial Number

85571350

Owner

GLAXO GROUP LIMITED

Attorney

Christopher M. Hanes

Filing Date

Mar 16, 2012

Add to watchlist:

No watchlists yet
View on USPTO

SPANSIV Trademark

Serial Number: 85571350

SPANSIV is a trademark filed by GLAXO GROUP LIMITED on March 16, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GLAXO GROUP LIMITED (5,077 trademarks)

980 Great West Road
Brentford, Middlesex TW89GS , GB

Entity Type: 03

Trademark Details

Filing Date

March 16, 2012

Registration Date

Not Registered

Published for Opposition

July 17, 2012

Goods & Services

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 15, 2013 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 14, 2013 ABN6
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2013 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2013 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2013 EXRA
SOU EXTENSION 1 GRANTED
Feb 15, 2013 EX1G
SOU EXTENSION 1 FILED
Feb 15, 2013 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 15, 2013 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 11, 2012 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 17, 2012 NPUB
PUBLISHED FOR OPPOSITION
Jul 17, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2012 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jun 11, 2012 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 8, 2012 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2012 CNSA
ASSIGNED TO EXAMINER
Jun 5, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2012 NWOS
NEW APPLICATION ENTERED
Mar 20, 2012 NWAP